Commission Opens First European Innovation Council Calls Worth €1 Billion
Following the launch of the European Innovation Council (EIC) and the announcement of the first funding opportunities, today the Commission opened the first EIC Accelerator calls. The funding worth over €1 billion aims to help scale up start-ups and small and medium-sized businesses that have the potential to achieve high impact. While over half of the funding is open to breakthrough innovations in any field, €495 million are earmarked for innovations that support the European Green Deal as well as digital and health technologies.
Read more ...
Accelerating Data Solutions to Save LIVES from COVID-19
The consortium of COVID-X announces the launch of the 1st Open Call framed in a 2-year initiative that will invest 4 million € to fast-track to market 30+ European data technology solutions defeating COVID-19 Challenges, facilitating an innovative stack of AI-driven tools.
Read more ...
Open Call SC1-HCO-18-2020: Developing Methodological Approaches for Improved Clinical Investigation and Evaluation of High-Risk Medical Devices
In May 2017, a new Regulation on medical devices, Regulation (EU) 2017/745 entered into force that will come into effect in spring 2020. This new Regulation sets forth reinforced rules for the generation of clinical evidence: for instance, clinical investigations for high-risk devices will be compulsory and the requirements regarding the clinical evaluation throughout the product lifetime are more stringent.
Open Call SC1-HCO-19-2020: Reliable and Accessible Information on Cell and Gene-Based Therapies
Cell and gene-based therapies have the potential to treat many debilitating diseases and conditions. However, the pace of their clinical development does not meet public expectations. They face difficulties reaching patients because inter alia the complexity and costs of product development, regulatory hurdles and the non-harmonized procedures for reimbursements. In addition, there are concerns over patient safety due to the use of unproven treatments.
Read more ...
Open Call SC1-HCO-20-2020: Coordination of Clinical Research Activities of the European Reference Networks
European Reference Networks (ERNs) have been established under the Directive on Patients' rights in cross-border health care in view of tackling complex or rare diseases and conditions that require highly specialised diagnostic tools and treatments. ERNs in collaboration with other European initiatives will gain major research potential due to their network structure bringing together highly specialised multidisciplinary expertise
Read more ...
Open Call SC1-BHC-20B-2020: Public Procurement of Innovative Solutions (PPI) for Diagnostics for Infectious Diseases
Implementation of timely and correct diagnostics for infectious diseases (ID) that will speed up the identification of the causative infectious disease pathogens, possible drug resistances and drug susceptibility is crucial for tailoring the antimicrobial treatment, thus ensuring appropriate antimicrobial drug use.
Read more ...
Open Call SC1-BHC-20A-2020: Pre-Commercial Procurement (PCP) for Integrated Care Solutions
The challenge is to enable public procurers to collectively implement PCPs in order to close the gap between supply and demand for innovative integrated care solutions. The objective is to bring radical improvements to the quality and efficiency of public services and service delivery by encouraging the development and validation of breakthrough solutions through Pre-Commercial Procurement.
Read more ...
Following the launch of the European Innovation Council (EIC) and the announcement of the first funding opportunities, today the Commission opened the first EIC Accelerator calls. The funding worth over €1 billion aims to help scale up start-ups and small and medium-sized businesses that have the potential to achieve high impact. While over half of the funding is open to breakthrough innovations in any field, €495 million are earmarked for innovations that support the European Green Deal as well as digital and health technologies. 